
FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
ALS results in muscles that are reduced in size (atrophic), weak, and soft, or muscles that are stiff, tight, and spastic.
Clinical Pearl of the Day: Amyotrophic lateral sclerosis (ALS) disease
ALS is a disease that impacts the parts of the nervous system that control voluntary muscle movement.
Explanation:
Sources:
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Subscribe




